Recent Technological Innovation in Peptide and Oligonucleotide Manufacturing

Yoshitaka Nemoto, Vice President R&D, PeptiStar

Recent Technological Innovation in Peptide and Oligonucleotide Manufacturing

Click to watch video

To accelerate the development of peptides and oligonucleotides as pharmaceuticals, it is necessary to develop technologies that overturn traditional approaches and overcome cost and quality challenges in all manufacturing processes, including synthesis, purification, and freeze-drying. We will introduce specific examples of new technologies that can solve these issues using our model compounds.

Yoshitaka Nemoto is currently responsible for the R&D department at PeptiStar. Nemoto has been working in the peptide industry for over 25 years since he was in university. Prior to PeptiStar, he worked at American Peptide Company in the US for several years and PeptiDream in Japan for about two years. During his time working at these companies, he was involved in numerous peptide project including process development and manufacturing of API in both US and Japan.